TScan Therapeutics, Inc. (TCRX)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
24
$10.67B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Management | Aug 13, 2026 | $2.12B |
| TWO SIGMA INVESTMENTS, LP | Aug 14, 2026 | $1.91B |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $1.30B |
| MILLENNIUM MANAGEMENT LLC | Aug 14, 2026 | $1.14B |
| CITADEL ADVISORS LLC | Aug 14, 2026 | $989.03M |
TCRX's filings are public. The insight is one click away.
Scrutar's AI reads every TCRX filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze TCRX filingsNo credit cardAI reports included on the free plan
Never miss a TCRX filing.
Get an email when TCRX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 31, 2026Source: SEC EDGAR.